SEARCH:      Monitor Keywords |  Custom RSS

Organic compounds -- part of the class 532-570 series April category listing, related patent applications 04/11

20110098485 - Bidentate secondary phosphine oxide chiral ligands for use in asymmetric addition reactions: Compounds of the formula I, in the form of mixtures comprising predominantly one enantiomer or in the form of pure enantiomers, secondary phosphine-Q-P*(═O)HR1 (I) in which secondary phosphine is a C-bonded, secondary phosphine group —P(R)2; in which R is in each case independently hydrocarbon radicals or heterohydrocarbon radicals; Q is... Agent:

20110098486 - Aromatic enediyne derivative, organic semiconductor thin film, electronic device and methods of manufacturing the same: Disclosed are a novel aromatic enediyne derivative, an organic semiconductor thin film using the same, and an electronic device. Example embodiments pertain to an aromatic enediyne derivative which enables the formation of a chemically and electrically stable and reliable semiconductor thin film using a solution process, e.g., spin coating and/or... Agent:

20110098487 - Novel color-forming compounds and use thereof in imaging members and methods: There are described novel rhodamine color-forming compounds. The rhodamine color-forming compounds exhibit a first color when in a crystalline form and a second color, different from the first color, when in an amorphous form. Thermal imaging members containing these color-formers are also described.... Agent: Zink Imaging, Inc.

20110098488 - Process for oxidizing organic substrates by means of singlet oxygen using a modified molybdate ldh catalyst: Oxidation of organic substrates by means of singlet oxygen, in which organic substrates which react with 1O2 are admixed with 10-70% H2O2 in an organic solvent in the presence of a molybdate LDH catalyst modified by ethylene glycol, polyethylene glycol or polyol, and the catalytic decomposition of H2O2 to water... Agent:

20110098489 - Process for production of benzaldehyde compound: (wherein, Q represents a hydrogen atom or a halogen atom, X represents a halogen atom, and Ar represents a phenyl group optionally substituted with at least one group selected from the group consisting of alkyl groups having 1 to 4 carbon atoms and halogen atoms.) and an alcohol compound in... Agent: Sumitomo Chemical Company, Limited

20110098490 - Process for preparation of formate salt: Processes for the recovery of formate salt from biomass and the product obtained thereof generally include subjecting an aqueous liquid mixture containing levulinic acid, formic acid and possibly furfural to a liquid-liquid extraction process, followed by the recovery of the furfural, the formate salt and the levulinic acid or the... Agent: Kemira Oyj

20110098491 - Direct epoxidation process using alkanoic acid modifier: The invention is a process for epoxidizing an olefin with hydrogen and oxygen in the presence of an alkanoic acid and a catalyst comprising a noble metal and a titanium zeolite, wherein the catalyst has not been reduced prior to epoxidation. This process surprisingly gives significantly improved productivity and reduced... Agent:

20110098492 - Cleaning compositions containing mid-range alkoxylates: Cleaning compositions are described comprising mid-range alkoxylate surfactants or blends of alkoxylate surfactants, and their use as cleaners for triglycerides and cross-linked triglycerides, formula stabilization agents, agents for ultra-concentrated cleaning formulations, pre-wash spotters, detergents, agricultural adjuvants, hard surface cleaning, and emulsifiers.... Agent:

20110092718 - Polymerizable chiral compounds comprising 2,6-naphthyl and isomannitol units, and use thereof as chiral dopants: P

20110092719 - Preparation of escitalopram, its salts and intermediates: The present patent application relates to an improved process for the preparation of escitalopram, its salts and intermediates. It also relates to a novel crystalline form S of citalopram diol intermediate, process for preparation and its use in the preparation of citalopram, escitalopram and their salts.... Agent: Shodhana Laboratories Limited

20110092720 - Method of producing 2,5-furandicarboxylic acid: Provided is a method of producing FDCA by which high-purity FDCA can be produced in high yield. 2,5-furandicarboxylic acid is produced by: bringing 5-hydroxymethylfurfural into contact with an oxidant in an organic acid solvent in the presence of bromine and a metal catalyst; and allowing 5-hydroxymethylfurfural and the oxidant to... Agent: Canon Kabushiki Kaisha

20110092721 - Process: A process for activating a reduced manganese copper catalyst comprising treating the catalyst at a temperature of more than 300° C. to about 400° C. with hydrogen.... Agent: Davy Process Technology Limited

20110087034 - Organic semiconductor material: P

20110087036 - Process for preparing dihydropyran and its use as protective agent: A process for the protection of a compound having at least one reactive functional group selected from hydroxy, mercapto, carboxyl, amino and amide, with 3,4-dihydro-2H-pyran (DHP), wherein said DHP is obtained by contacting tetrahydrofurfuryl alcohol (THFA) entrained in a carrier gas with a catalyst comprising aluminium oxide (Al2O3), and wherein... Agent:

20110087035 - Process for the preparation of dihydropyran: The present invention relates to a process for the preparation of 2,3-dihydropyran (DHP, CAS [110-87-2]) and its use in industrial chemistry.... Agent:

20110082303 - Process for the manufacture of laidlomycin: Improved process for the isolation of laidlomycin from a fermentation broth includes increasing the pH of the fermentation broth and centrifuging the pH adjusted fermentation broth, resulting in an aqueous layer and a wet solid layer containing laidlomycin. After the aqueous layer is removed, the wet solid layer containing laidlomycin... Agent: Alpharma Inc.

20110082304 - Method for the synthesis of 5-hydroxymethylfurfural ethers and their use: Method for the manufacture of 5-hydroxymethylfurfural derivatives by reacting a fructose and/or glucose-containing starting material with an alcohol in the presence of a catalytic or sub-stoichiometric amount of solid (“heterogeneous”) acid catalyst. The catalysts may be employed in a continuous flow fixed bed or catalytic distillation reactor. The ethers can... Agent: Furanix Technologies B.v.